Dennis E. van Epps

Dennis E. van Epps

Geen lopende functies

Consumer Services
Commercial Services
Health Technology

Profiel

Dr. Van Epps has served as our Vice President, Research since November 2001.
From 2000 to 2001, Dr. Van Epps served as Vice President of Research and Development, and from 1997 to 2000 as Vice President, Research, and an officer at Nexell Therapeutics, a publicly-traded biotechnology company.
From 1993 to 1997, Dr. Van Epps served as Vice President of Research for Baxter Healthcare Corporation's Immunotherapy Division and as a Director at the Applied Cell Biology Center from 1988 to 1993.
From 1985 to 1988, Dr. Van Epps was a Professor of Medicine and Pathology at the University of New Mexico School of Medicine.
Prior to 1985 he held positions as Associate Professor of Medicine and Pathology and Assistant Professor of Medicine and Microbiology at the same medical school.
Dr. Van Epps obtained his postdoctoral training in immunology in the Department of Medicine at the University of New Mexico and has published over 135 manuscripts in the fields of immunology, cell therapy, inflammation and stem cell biology.
He is also an inventor on nine patents in the fields of human cell selection technology, stem cell culture and cell therapy.
Dr. Van Epps received a B.S.
degree in zoology from Western Illinois University and a Ph.D.
in microbiology and immunology from the University of Illinois Medical School in Chicago, Illinois.

Eerdere bekende functies van Dennis E. van Epps

BedrijvenFunctieEinde
CancerVax Corp. Hoofd Techniek/Wetenschap/O&O 09-05-2006
Hoofd Techniek/Wetenschap/O&O 15-04-2006
Ervaring van Dennis E. van Epps in detail bekijken

Opleiding van Dennis E. van Epps

Western Illinois University Undergraduate Degree
University of Illinois Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Dennis E. van Epps in detail bekijken

Verwante bedrijven

Bedrijven in privébezit2
CancerVax Corp.

Commercial Services

Health Technology

  1. Beurs
  2. Insiders
  3. Dennis E. van Epps
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU